Drug intelligence / Profile preview

Arnidol

Development stage
Unknown
Lead developer
Diafarm
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Arnidol is a line of natural topical health products developed by Diafarm, a subsidiary of Faes Farma, primarily targeted at the pediatric market for the treatment of minor bumps and skin irritations. The core product, Arnidol Gel Stick, utilizes a combination of Arnica (*Arnica montana*) and Devil's Claw (*Harpagophytum procumbens*) extracts. Arnica is rich in helenalin, which possesses anti-inflammatory properties by inhibiting the NF-kappaB signaling pathway, while Devil's Claw contains harpagosides that inhibit COX-2 activity. Together, these ingredients work to soothe the skin, reduce swelling, and provide mild analgesic effects following minor physical trauma. The brand has expanded to include specialized products like Arnidol Pic (for insect bites), Arnidol Sun (mineral sun protection), and Arnidol Active Gel (for muscle recovery).

Brand names
ArnidolArnidol Gel StickArnidol PicArnidol SunArnidol Active Gel
02

Targets

NF-κBPTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Arnidol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arnidol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call